[Lenovo's first ultra-small desktop with powerful AI functions was unveiled at CES2024].
On January 9, at CES2024, Lenovo unveiled new ThinkBook products, ThinkCentre desktops, and accessories for the small and medium-sized business (SMB) market with innovative features, intelligent design, and AI PC enhancements. As Lenovo's first ultra-small desktop with powerful AI capabilities, the ThinkCentre Neo Ultra is officially unveiled. The desktop uses CPUs, discrete NPUs, and GPUs to complement and work together to deliver the best performance by maximizing resources and allocating the best activities to the right programs.
Wanhua Chemical: The first phase of the MDI plant (400,000 tons per year) and the second phase of the MDI plant (800,000 tons per year) in Ningbo Industrial Park are still being overhauled as planned
Wanhua Chemical Ningbo Industrial Park has a capacity of 400,000 tonnes per year for MDI Phase 1 and 800,000 tonnes per year for MDI Phase II. At present, the two units are undergoing maintenance work as planned.
Baili Technology: Signed 83.8 billion yuan major contract].
Baili Technology (603959) announced on the evening of January 9 that the company signed a contract with Shanxi Twashi Energy Technology Co., Ltd. (hereinafter referred to as "Shanxi Twashi"), which involves the design, procurement and construction of Shanxi Twashi Energy Technology Co., Ltd.'s annual output of 100,000 tons of lithium manganese iron phosphate cathode material project. The total price of the contract is 83.8 billion yuan, accounting for 26 percent of the company's audited operating income in the latest year04%γIt is expected that if the contract can be successfully fulfilled on schedule, it will have a positive impact on the company's current and future operating results.
Xinlian Integration plans to cooperate with Shaoxing Fuzhejiang Yuexin Integrated Circuit Industry Equity Investment ** Partnership (Limited Partnership).
In order to ensure the smooth progress of the "Phase III 12-inch integrated circuit digital-analog hybrid chip manufacturing project", it is planned to increase the capital of the first phase of Xinlian Pioneer 385 billion yuan. Among them, the company will increase its capital by 2887.5 billion yuan, accounting for 75% of the total capital increase.
Samsung Medical: Subsidiary won the bid for 83.6 billion yuan framework procurement of wind power photovoltaic prefabricated substation (Chinese, oil transformer) project].
Samsung Medical (601567) announced on the evening of January 9 that the company recently received a notice from its wholly-owned subsidiary, Oaks Intelligent Technology, that it won the bid for the 2024-2025 framework procurement of wind power photovoltaic prefabricated substations (Chinese-style, oil transformers) in the China Datang Group. Oaks Intelligent Technology successfully won the bid for the project, with a total amount of about 83.6 billion yuan, accounting for 9. % of the company's audited total operating income in 202219%γ
Changchun High-tech: Recombinant human follicle-stimulating hormone injection of a holding subsidiary obtained the "Drug Registration Certificate".
Changchun High-tech recently announced that its holding subsidiary has successfully completed the restructuring, and the follicle-stimulating hormone injection it produces has obtained the "Drug Registration Certificate".
Sichuan Investment Energy Performance Express: Net profit in 2023 will be 4.4 billion yuan, a year-on-year increase of 2526%γ
Sichuan Investment Energy released its 2023 performance report, showing that its net profit was 4.4 billion yuan, an increase of 2526%γ
In 2023, the general outpatient clinic will be basically established for employee medical insurance, and the reimbursement amount will exceed 200 billion yuan
On January 9, Beijing held a national conference on medical security. The meeting pointed out that by 2023, a general outpatient co-ordination system for employee medical insurance will be basically established, covering more than 400,000 medical institutions. It is expected that more than 2.5 billion people will be reimbursed during the year, and the reimbursement amount will exceed 200 billion yuan. In addition, two batches of state centralized procurement covering 80 drugs are planned to be carried out during the year, with an average price reduction of 57%. At the same time, it will also carry out centralized procurement of intraocular lenses and sports medicine consumables, with an average price reduction of 70%. Special treatment measures will also be carried out for the charges and consumables for dental implant medical services**, and it is expected that the overall cost of a single dental implant will increase from an average of 150,000 yuan will drop to about 6,000-7,000 yuan, and the cumulative number of planted will reach 1.5 million.
List of high-quality authors